State Ledger
Company profile

Cingulate Inc. CIK 1862150

Tickers
CING (Nasdaq) · CINGW (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Kansas City, KS 66205
Fiscal year end
2025 (FY)
Market Data
Close
$4.85
Change
-$0.05
Change %
-1.02%
Volume
977

CING · trading date Oct 12, 2026 · previous close $4.90 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$22.45M
Total assets
$15.07M
Total liabilities
$12.56M
Stockholders' equity
$2.51M
Cash & equivalents
$10.95M
Operating income
-$19.94M
Operating cash flow
-$17.25M
Capital expenditures
$162.1K

Fiscal year 2025, via 10-K filed 2026-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$17.41M
Free cash flow margin
—
Liabilities / assets
83.4%
Equity / assets
16.6%
CapEx / revenue
—
Operating cash flow / net income
0.77×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$22.45M $15.07M $12.56M $2.51M
2024 — -$16.56M $14.86M $7.41M $7.46M
2023 — -$23.53M $3.49M $10.36M -$6.87M
2022 — -$17.68M $11.41M $7.52M $3.88M
2021 — -$20.71M $22.89M $2.04M $20.84M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-13
Financials filed via
Form 10-K
filed 2026-03-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Kansas City, KS 66205
1901 W. 47TH PLACE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:31 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Kansas — Public Companies